Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair

被引:18
作者
Colnaghi, Luca [1 ,2 ,3 ]
Jones, Mathew J. K. [1 ]
Cotto-Rios, Xiomaris M. [1 ,2 ]
Schindler, Detlev [4 ]
Hanenberg, Helmut [5 ,6 ]
Huang, Tony T. [1 ]
机构
[1] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA
[2] NYU, Sch Med, Sackler Grad Program Cellular & Mol Biol, New York, NY 10016 USA
[3] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy
[4] Univ Wurzberg, Dept Human Genet, Wurzburg, Germany
[5] Univ Dusseldorf, Childrens Hosp, Dept Pediat Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany
[6] Indiana Univ Sch Med, James Whitcomb Riley Hosp Children, Dept Pediat, Indianapolis, IN USA
基金
美国国家卫生研究院;
关键词
INTERSTRAND CROSS-LINK; ANEMIA PATHWAY; NUCLEAR ACCUMULATION; MONOUBIQUITINATED FANCD2; DAMAGE RESPONSE; HELICASE BRIP1; BREAST-CANCER; IDENTIFICATION; LOCALIZATION; COMPLEX;
D O I
10.1182/blood-2010-07-295758
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Fanconi anemia (FA) is a rare familial genome instability syndrome caused by mutations in FA genes that results in defective DNA crosslink repair. Activation of the FA pathway requires the FA core ubiquitin ligase complex-dependent monoubiquitination of 2 interacting FA proteins, FANCI and FANCD2. Although loss of either FANCI or FANCD2 is known to prevent monoubiquitination of its respective partner, it is unclear whether FANCI has any additional domains that may be important in promoting DNA repair, independent of its monoubiquitination. Here, we focus on an FA-I patient-derived FANCI mutant protein, R1299X (deletion of 30 residues from its C-terminus), to characterize important structural region(s) in FANCI that is required to activate the FA pathway. We show that, within this short 30 amino acid stretch contains 2 separable functional signatures, a nuclear localization signal and a putative EDGE motif, that is critical for the ability of FANCI to properly monoubiquitinate FANCD2 and promote DNA crosslink resistance. Our study enable us to conclude that, although proper nuclear localization of FANCI is crucial for robust FANCD2 monoubiquitination, the putative FANCI EDGE motif is important for DNA crosslink repair. (Blood. 2011;117(7): 2247-2256)
引用
收藏
页码:2247 / 2256
页数:10
相关论文
共 49 条
[1]
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants [J].
Adachi, D ;
Oda, T ;
Yagasaki, H ;
Nakasato, K ;
Nakasato, K ;
Taniguchi, T ;
D'Andrea, AD ;
Asano, S ;
Yamashita, T .
HUMAN MOLECULAR GENETICS, 2002, 11 (25) :3125-3134
[2]
ATR couples FANCD2 monoubiquitination to the DNA-damage response [J].
Andreassen, PR ;
D'Andrea, AD ;
Taniguchi, T .
GENES & DEVELOPMENT, 2004, 18 (16) :1958-1963
[4]
Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis [J].
Bienko, M ;
Green, CM ;
Crosetto, N ;
Rudolf, F ;
Zapart, G ;
Coull, B ;
Kannouche, P ;
Wider, G ;
Peter, M ;
Lehmann, AR ;
Hofmann, K ;
Dikic, I .
SCIENCE, 2005, 310 (5755) :1821-1824
[5]
The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair [J].
Bridge, WL ;
Vandenberg, CJ ;
Franklin, RJ ;
Hiom, K .
NATURE GENETICS, 2005, 37 (09) :953-957
[6]
MECHANISMS OF DISEASE Susceptibility Pathways in Fanconi's Anemia and Breast Cancer [J].
D'Andrea, Alan D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (20) :1909-1919
[7]
IDENTIFICATION OF THE HUMAN C-MYC PROTEIN NUCLEAR TRANSLOCATION SIGNAL [J].
DANG, CV ;
LEE, WMF .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) :4048-4054
[8]
Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin [J].
de Oca, RM ;
Andreassen, PR ;
Margossian, SP ;
Gregory, RC ;
Taniguchi, T ;
Wang, XZ ;
Houghtaling, S ;
Grompe, M ;
D'Andrea, AD .
BLOOD, 2005, 105 (03) :1003-1009
[9]
The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage [J].
Dequen, F ;
St-Laurent, JF ;
Gagnon, SN ;
Carreau, M ;
Desnoyers, S .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2005, 141 (04) :453-460
[10]
Dorsman JC, 2007, CELL ONCOL, V29, P211